20/20 Biolabs, Inc. (AIDX) at a glance

20/20 Biolabs, Inc. (AIDX) is a micro-cap Healthcare company. It trades at $0.58, with a -279.1% profit margin and revenue decline of 36.2%. It does not pay a dividend. Vestovix scores it 31/100 overall. Its strongest dimension is Safety (46/100) and its weakest is Growth (12/100).

Price
$0.58
Market cap
$10.2M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$0.54 to $50.00
Vestovix Score31/ 100How this works
Value
40
Growth
12
Income
40
Safety
46
Momentum
12

Other Healthcare stocks

See all